Table 3.

Prevalence of ONJ [43].

Type of study		Type of bisphosphonate
Overall prevalence	6.1%	Zoledronic acid	8.6%
Documented Follow up	13.3%	Pamidronate	7.3%
No documented follow up	0.7%	Both	21%
Epidemiologic studies	1.2%	Oral BP	0.1–4%